Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification - Test2 - elhamkhani - TriplyDB

Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification

Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification

http://www.wikidata.org/entity/Q27315772

about

Subversion of innate defenses by the interplay between DENV and pre-existing enhancing antibodies: TLRs signaling collapse Characterization of Lethal Zika Virus Infection in AG129 Mice Zika Virus: Medical Countermeasure Development Challenges Mouse models of dengue virus infection for vaccine testing An in-depth analysis of original antigenic sin in dengue virus infection Mosquito Saliva Increases Endothelial Permeability in the Skin, Immune Cell Migration, and Dengue Pathogenesis during Antibody-Dependent Enhancement Structural basis of potent Zika–dengue virus antibody cross-neutralization Zika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical Transmission Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials Pathogenesis of Dengue: Dawn of a New Era Dengue Hemorrhagic Fever at 60 Years: Early Evolution of Concepts of Causation and Treatment Mouse models to study dengue virus immunology and pathogenesis A model of DENV-3 infection that recapitulates severe disease and highlights the importance of IFN-γ in host resistance to infection IFN-γ production depends on IL-12 and IL-18 combined action and mediates host resistance to dengue virus infection in a nitric oxide-dependent manner Hierarchical Cluster Analysis of Three-Dimensional Reconstructions of Unbiased Sampled Microglia Shows not Continuous Morphological Changes from Stage 1 to 2 after Multiple Dengue Infections in Callithrix penicillata.Rational design of a live attenuated dengue vaccine: 2'-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaques How antibodies alter the cell entry pathway of dengue virus particles in macrophages Arbovirosis and potential transmission blocking vaccines The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1 Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope Structural insights into the neutralization mechanism of a higher primate antibody against dengue virus Structural Analysis of a Dengue Cross-Reactive Antibody Complexed with Envelope Domain III Reveals the Molecular Basis of Cross-Reactivity A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface Drivers of Inter-individual Variation in Dengue Viral Load Dynamics The complexity of antibody-dependent enhancement of dengue virus infection Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue Dengue research opportunities in the Americas The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis The Complement System in Flavivirus Infections Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity Biologic Evidence Required for Zika Disease Enhancement by Dengue Antibodies Molecular engineering and plant expression of an immunoglobulin heavy chain scaffold for delivery of a dengue vaccine candidate ADE-ing and Abetting Zika.Characterization of Zika virus binding and enhancement potential of a large panel of flavivirus murine monoclonal antibodies.Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope 18F-FDG as an inflammation biomarker for imaging dengue virus infection and treatment response Influenza and dengue virus co-infection impairs monocyte recruitment to the lung, increases dengue virus titers, and exacerbates pneumonia.Generation and analysis of novel plant-derived antibody-based therapeutic molecules against West Nile virus.

P2860

Q21144516-DBB16216-ABD9-4FE6-B4BD-849CE591EE80 Q24082695-AB80566C-6842-4846-A7F8-611F980C730F Q24261184-2A0579CB-9DFB-4A11-BB60-1E253629BD9B Q24276139-198DF910-4AB8-4A9D-9353-8DA8A7600D76 Q24606493-FC8EBB13-C8EF-4F25-A978-14F948D22A84 Q24655645-455EA3A5-E225-44F4-861A-48815D709879 Q24740325-A626A8FB-8625-411A-9D9D-32B840575511 Q26252081-FFDCA67E-8A98-4CBA-9517-524F7D5F8D91 Q26314452-88C50AFE-596B-4D9E-B8DF-16A53C6C7AD8 Q26700096-9B708442-B78F-48C7-8074-9E38FF039B0B Q26766198-3F5EB12D-650D-4850-A734-BAD4E52838DF Q26827164-7FD7C879-F56B-4112-8747-1577C55D4B29 Q27010151-EEB02DE5-946D-488A-BC13-36668B24E837 Q27305445-45CAD700-BE28-4020-9110-34E866311FC0 Q27305770-9509DAD1-5B95-4D41-91AB-7E252A901C6A Q27322804-A8D24617-BDA1-4CA9-A237-41B1B8E6F7E1 Q27334248-DEE4F570-467E-44EC-A7E7-E21B39AFD4C4 Q27334575-CD077D25-46A9-4148-9A60-B0816E091185 Q27468657-B04427B3-607D-4C78-B7CD-6474CE6C9587 Q27491317-F1CEC183-797B-4BA5-9C77-4B9DF57E801C Q27654848-3E1CCE09-9A56-4B3B-A20D-A8256065D049 Q27674417-8EF7AADF-6AA0-4277-9444-174AEF7329F5 Q27675965-0C129DB0-5EC2-48EE-947C-E0503EE65D5F Q27678419-1E52675F-DDF7-4E5E-9178-528652317DC3 Q27681319-4285B67C-AC11-483F-B147-7E6F956C0617 Q27882968-C904B29C-032D-45E9-BA2B-D399948BFAC7 Q28250383-78979940-9080-4943-8667-ADAF03E03948 Q28476805-3D50BB01-73D9-4C7C-8AD7-583F2D84B182 Q28656204-7DB7415F-4DE1-436A-A67D-E4D010EB7B58 Q28804225-93DE85D7-1125-4802-82C0-96D1DFE9E5CF Q28954726-5E88CE4C-BD85-42C4-843C-2C5DF6509628 Q29196526-681D515D-8448-4D46-A619-31B4032DDF51 Q29365355-AD8B3D7E-6E59-4C2F-9648-440031E59B08 Q29587283-703889B0-3CB4-457E-8FC1-A4D530ABB7CE Q30145626-84317E98-079C-4F7A-8BD2-B9FC7646E4B5 Q30145645-60F19E79-79C9-45E0-B581-41ACD9676D9E Q30250932-8C48534F-8384-4E75-B0F7-42CE43BF41D8 Q30250993-0CAB1FA4-8130-4902-B78F-7E1DE2256FFC Q30396651-68F5736C-34E0-49B6-9283-4F15590AC729 Q31154829-B5EF4059-30E4-4651-A3A1-B4DB421887E7

P2860

Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification

http://www.wikidata.org/entity/Q27315772

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification

@ast

Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification

@en

Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification

@nl

type

label

Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification

@ast

Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification

@en

Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification

@nl

altLabel

Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification

@en

prefLabel

Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification

@ast

Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification

@en

Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification

@nl

P1433

Q27315772-2AAA0F3E-99C9-4F23-B00F-FD1DA3E46679

P1476

Q27315772-7DE6F696-E589-4983-80A5-83EB3A2BE37A

P2093

Q27315772-012A1C31-FD72-4685-B97D-2F572ADBCECB

Q27315772-184825AB-F29C-4DC3-A2FF-E2D48FEB5852

Q27315772-23607008-2809-4A22-B9BB-C64C7B01965E

Q27315772-55D04E97-1689-4186-9AE4-1983EE214A06

Q27315772-9042C352-629A-46B6-AFB0-A9F1734DD3B3

Q27315772-9D9E7060-621C-4861-B5FB-77E22D61994C

Q27315772-F207FCCB-0CC9-4CA6-85E7-9E7CDBC20B23

Q27315772-FCCF716C-4E50-4713-8CAE-4A4C3E45295D

P2860

Q27315772-0078719D-C4B4-4AA4-8B83-B155782CB913

Q27315772-0109F30E-08C4-4A4A-92DD-552BBD9E7A70

Q27315772-018B3993-127B-49C8-B9BC-01EF350C3340

Q27315772-03A920BC-7E38-4F7D-A074-ACD71BFE5684

Q27315772-07E48A88-7FFD-45BD-ACF0-96205B7E7DDA

Q27315772-0CB9628D-C52A-48FB-91C4-53312367E85F

Q27315772-3583DD08-0211-4F87-B1A3-E71CF006DD5F

Q27315772-403379AE-43BA-4AAA-9610-478E4C4156CD

Q27315772-40E9265F-3C76-4001-898C-89ACCF570FB2

Q27315772-419DD59E-B9A9-4C8D-9424-D52A6535F444

P304

Q27315772-9C743E3E-735E-426F-8941-B6F1311BA491

P31

Q27315772-577D44F3-4184-4D5A-A7D1-2D62FD3D5671

P3181

Q27315772-2FC6BFAA-10FB-4238-86AD-D74038077BDD

P356

Q27315772-35DAD2D3-10E4-4227-89B3-48E2C8BC1840

P407

Q27315772-3B74EE3D-43CB-4F2D-AE95-09579CAFFC85

P433

Q27315772-824CD369-E901-4925-BD76-F6C04BC499B3

P478

Q27315772-22FC7BAD-3E48-46C7-A923-3BA6A3D45BA6

P50

Q27315772-4C0D97D3-A0D5-43DE-AFC0-D01D34221E64

Q27315772-6EB8EC95-2B27-417D-B10E-35C9A33041AB

P5008

Q27315772-C6B24D3C-3BF8-4B6A-9756-A5F0A64AB1C5

P577

Q27315772-02FC77E8-C11B-4DBD-A7CA-C8F276A888F1

P5875

Q27315772-71085C53-B463-40E3-91BC-3FC1B4142CED

P698

Q27315772-7061B1DC-3102-453E-9181-BBFB629673AD

P921

Q27315772-2844E8A1-5D49-4E21-98CC-C720439B67E5

Q27315772-BDEF0A51-EEAE-41C5-B29C-4B8D04615F86

P932

Q27315772-3CA19AD6-27A2-45C9-AFB2-7CDF6FA3C479

P3181

P356

JOURNAL.PPAT.1000790

P1433

P1476

Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification

@en

P2093

Diana Flores

http://www.w3.org/2001/XMLSchema#string

Erin Mehlhop

http://www.w3.org/2001/XMLSchema#string

Jennifer L Kyle

http://www.w3.org/2001/XMLSchema#string

Katherine L Williams

http://www.w3.org/2001/XMLSchema#string

P Robert Beatty

http://www.w3.org/2001/XMLSchema#string

Ruben Lachica

http://www.w3.org/2001/XMLSchema#string

Scott J Balsitis

http://www.w3.org/2001/XMLSchema#string

Syd Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease

A Dengue Fever Viremia Model in Mice Shows Reduction in Viral Replication and Suppression of the Inflammatory Response after Treatment with Antiviral Drugs

Localization and Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes

Dengue: defining protective versus pathologic immunity

Role of dendritic cells in antibody-dependent enhancement of dengue virus infection

Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention

Study of Dengue virus infection in SCID mice engrafted with human K562 cells.

Dengue virus structural differences that correlate with pathogenesis.

Dengue Fever in Humanized NOD/SCID Mice

Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus

P304

e1000790

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

199653

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PPAT.1000790

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Michael S. Diamond

P5008

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41487623

http://www.w3.org/2001/XMLSchema#string

P698

20168989

http://www.w3.org/2001/XMLSchema#string

P921

P932

2820409

http://www.w3.org/2001/XMLSchema#string